Hinge Health (HNGE) insider converts Class B to Class A and gifts 11,680 shares

Rhea-AI Filing Summary

Hinge Health, Inc. reported an insider transaction by a person who is a director, CEO, co‑founder and 10% owner. On 12/10/2025, the insider converted 11,680 shares of Class B Common Stock into 11,680 shares of Class A Common Stock at a stated price of $0 per share. On 12/12/2025, those 11,680 Class A shares were transferred as a gift, leaving the insider with 0 directly held Class A shares.

Following these transactions, the insider reported 14,710,097 derivative securities related to Class B Common Stock held directly, and an additional 515,705 derivative securities and 35,470 Class A shares held indirectly through a spouse. Each share of Class B Common Stock is convertible into one share of Class A Common Stock under conditions described in the company’s charter.

Insider Trade Summary

11,680 shares exercised/converted

Mixed 5 txns

Insider Perez Daniel Antonio

Role CEO & Co-Founder

Type	Security	Shares	Price	Value
Gift	Class A Common Stock	11,680	$0.00	--
Conversion	Class B Common Stock	11,680	$0.00	--
Conversion	Class A Common Stock	11,680	$0.00	--
holding	Class B Common Stock	--	--	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 0 shares (Direct); Class B Common Stock — 14,710,097 shares (Direct); Class B Common Stock — 515,705 shares (Indirect, By Spouse); Class A Common Stock — 35,470 shares (Indirect, By Spouse)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Perez Daniel Antonio

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & Co-Founder

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/10/2025		C		11,680	A	$0	11,680	D
Class A Common Stock	12/12/2025		G		11,680	D	$0	0	D
Class A Common Stock								35,470	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	(1)	12/10/2025		C			11,680	(1)	(1)	Class A Common Stock	11,680	$0	14,710,097	D
Class B Common Stock	(1)							(1)	(1)	Class A Common Stock	515,705		515,705	I	By Spouse

Explanation of Responses:

1. Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

	/s/ James Budge, Attorney-in-Fact	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hinge Health (HNGE) disclose in this Form 4?

The filing shows that a Hinge Health insider who is a director, CEO, co‑founder and 10% owner converted 11,680 Class B Common shares into 11,680 Class A Common shares on 12/10/2025 and then transferred those 11,680 Class A shares as a gift on 12/12/2025.

How many Hinge Health Class A shares does the insider hold after the reported transactions?

After the conversion and subsequent gift of 11,680 Class A shares, the insider reported 0 directly held Class A Common shares and 35,470 Class A Common shares held indirectly through a spouse.

What derivative holdings related to Hinge Health (HNGE) stock does the insider report?

The insider reported 14,710,097 derivative securities tied to Class B Common Stock held directly, plus 515,705 derivative securities related to Class B Common Stock held indirectly by a spouse, each representing underlying Class A Common Stock.

What is the relationship between Hinge Health Class B and Class A Common Stock?

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the holder’s election, or automatically upon certain transfers or events described in Hinge Health’s Amended and Restated Certificate of Incorporation.

What do the transaction codes C and G mean in the Hinge Health (HNGE) Form 4?

In this filing, code C indicates the conversion of 11,680 Class B shares into Class A shares on 12/10/2025, and code G indicates a gift of those 11,680 Class A shares on 12/12/2025, both at a stated price of $0 per share.

Is the Hinge Health insider a significant shareholder?

Yes. The individual is identified as a director, CEO & co‑founder, and a 10% owner of Hinge Health, Inc., and reports millions of derivative securities related to Class B Common Stock.